Egorova, A.; Petrosyan, M.; Maretina, M.; Bazian, E.; Krylova, I.; Baranov, V.; Kiselev, A.
iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis. Pharmaceutics 2023, 15, 2108.
https://doi.org/10.3390/pharmaceutics15082108
AMA Style
Egorova A, Petrosyan M, Maretina M, Bazian E, Krylova I, Baranov V, Kiselev A.
iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis. Pharmaceutics. 2023; 15(8):2108.
https://doi.org/10.3390/pharmaceutics15082108
Chicago/Turabian Style
Egorova, Anna, Mariya Petrosyan, Marianna Maretina, Elena Bazian, Iuliia Krylova, Vladislav Baranov, and Anton Kiselev.
2023. "iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis" Pharmaceutics 15, no. 8: 2108.
https://doi.org/10.3390/pharmaceutics15082108
APA Style
Egorova, A., Petrosyan, M., Maretina, M., Bazian, E., Krylova, I., Baranov, V., & Kiselev, A.
(2023). iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis. Pharmaceutics, 15(8), 2108.
https://doi.org/10.3390/pharmaceutics15082108